RT @ASBMR: Type I Angiotensin II Receptor Blockade Reduces Uremia‐Induced Deterioration of Bone Material Properties #JBMR https://t.co/c73hCnaAmz https://t.co/SPs9TjIPQe
Type I Angiotensin II Receptor Blockade Reduces Uremia‐Induced Deterioration of Bone Material Properties #JBMR https://t.co/c73hCnaAmz pic.twitter.com/SPs9TjIPQe
— ASBMR (@ASBMR) October 6, 2020
from Twitter https://twitter.com/GastonR48222321
October 07, 2020 at 08:15AM
Comentarios
Publicar un comentario